HIV AIDS: What is the new vaccine all about?

South Africa on Wednesday (November 30th) launched a clinical trial of more than 5,000 people who will test an experimental
vaccine against AIDS reported by RFI. This is the first time since the start of the pandemic that researchers are hopeful of finding an effective vaccine. The vaccine includes a product called biogenetics. It is not about HIV AIDS, nor about a lessened form of this virus. This is a synthetic copy that resembles the virus, which has the same structure, but that can not infect you. On the other hand this copy will cause a reaction, the production of antibodies that will help you to fight against HIV if you are exposed to the virus explains the doctor Mookha Mala-lheha who supervises the tests.